Operating Income (Loss) in USD of SPRUCE BIOSCIENCES, INC. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Spruce Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2025.
  • Spruce Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$8.23M, a 12.5% increase year-over-year.
  • Spruce Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$49.5M, a 14.4% decline year-over-year.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$56.2M, a 8% decline from 2023.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$52M, a 9.96% decline from 2022.
  • Spruce Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$47.3M, a 12.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

SPRUCE BIOSCIENCES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$49.5M -$8.23M +$1.18M +12.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$50.7M -$2.69M +$7.34M +73.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$58M -$14.5M -$1.86M -14.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 -$56.2M -$24.1M -$12.9M -116% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 -$43.2M -$9.41M +$4.25M +31.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$47.5M -$10M +$3.94M +28.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$51.4M -$12.6M +$566K +4.29% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 -$52M -$11.2M +$947K +7.82% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 -$52.9M -$13.7M -$2.1M -18.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$50.8M -$14M -$2.09M -17.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$48.7M -$13.2M -$1.47M -12.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$47.3M -$12.1M -$2.98M -32.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$44.3M -$11.6M -$157K -1.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$44.2M -$11.9M -$168K -1.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$44M -$11.7M -$1.92M -19.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$42.1M -$9.14M -$800K -9.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$41.3M -$11.4M -$1.84M -19.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$39.4M -$11.7M -$5.33M -83.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$34.1M -$9.82M -$4.68M -91.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$29.4M -$8.34M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$9.56M -$7M -273% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$6.39M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$5.13M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 -$2.56M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18

SPRUCE BIOSCIENCES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$56.2M -$4.16M -8% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$52M -$4.71M -9.96% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$47.3M -$5.22M -12.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$42.1M -$12.7M -43% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$29.4M -$16.3M -124% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$13.1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.